دورية أكاديمية
أعرض في EDS

Role of microRNAs deregulation in initiation of rheumatoid arthritis: A retrospective observational study.

التفاصيل البيبلوغرافية
العنوان: Role of microRNAs deregulation in initiation of rheumatoid arthritis: A retrospective observational study.
المؤلفون: Li Z; Department of Bone Surgery, Department of Orthopaedic Surgery Ⅱ, Affiliated Hospital of Beihua University, Jilin, China., Zhao W; Department of Orthopaedics, The first Affiliated Hospital of Chengdu Medical College, Chengdu City, Sichuan Province, China., Wang M; Department of Rehabilitation Medicine, Traditional Chinese Medical Hospital of HuZhou, Huzhou, Zhejiang, China., Hussain MZ; Department of Rheumatology, Military Hospital, Rawalpindi, Pakistan., Mahjabeen I; Cancer Genetics and Epigenetics Lab, Department of Biosciences, COMSATS University Islamabad, Islamabad, Pakistan.
المصدر: Medicine [Medicine (Baltimore)] 2024 Jan 19; Vol. 103 (3), pp. e36595.
نوع المنشور: Observational Study; Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hagerstown, Md : Lippincott Williams & Wilkins
مواضيع طبية MeSH: MicroRNAs*/genetics , MicroRNAs*/metabolism , Arthritis, Rheumatoid*/diagnosis, Humans ; Biomarkers/analysis ; Retrospective Studies ; Risk
مستخلص: Rheumatoid arthritis (RA) is a joint disorder and is considered an important public health concern nowadays. So, identifying novel biomarkers and treatment modalities is urgently needed to improve the health standard of RA patients. Factors involved in RA pathogenesis are genetic/epigenetic modification, environment, and lifestyle. In the case of epigenetic modification, the expression deregulation of microRNAs and the role of histone deacetylase (HDAC) in RA is an important aspect that needs to be addressed. The present study is designed to evaluate the expression pattern of microRNAs related to the HDAC family. Five microRNAs, miR-92a-3p, miR-455-3p, miR-222, miR-140, and miR-146a related to the HDAC family were selected for the present study. Real-time polymerase chain reaction was used to estimate the level of expression of the above-mentioned microRNAs in 150 patients of RA versus 150 controls. Oxidative stress level and histone deacetylation status were measured using the enzyme-linked immunosorbent assay. Statistical analysis showed significant downregulation (P < .0001) of selected microRNAs in RA patients versus controls. Significantly raised level of HDAC (P < .0001) and 8-hydroxy-2'-deoxyguanosine (P < .0001) was observed in patients versus controls. A good diagnostic potential of selected microRNAs in RA was shown by the receiver operating curve analysis. The current study showed a significant role of deregulated expression of the above-mentioned microRNAs in RA initiation and can act as an excellent diagnostic marker for this disease.
Competing Interests: The authors have no funding and conflicts of interest to disclose.
(Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.)
References: Br J Rheumatol. 1995 Mar;34(3):252-6. (PMID: 7728401)
J Control Release. 2013 Dec 28;172(3):962-74. (PMID: 24075926)
J Clin Transl Res. 2023 Feb 06;9(2):84-92. (PMID: 37034001)
Nat Rev Rheumatol. 2012 Sep;8(9):543-52. (PMID: 22890245)
J Clin Invest. 2021 Jun 15;131(12):. (PMID: 33914705)
Clin Exp Med. 2019 Feb;19(1):47-53. (PMID: 30132091)
Tumour Biol. 2016 Apr;37(4):4439-44. (PMID: 26499948)
Anticancer Res. 2017 Aug;37(8):4319-4327. (PMID: 28739724)
Pharmacol Res. 2018 Feb;128:73-79. (PMID: 28827187)
BMC Musculoskelet Disord. 2016 Feb 18;17:89. (PMID: 26891838)
Bone Res. 2023 Jan 24;11(1):8. (PMID: 36690624)
Cell Death Dis. 2018 May 10;9(5):537. (PMID: 29748607)
Genome Res. 2009 Jan;19(1):92-105. (PMID: 18955434)
Exp Mol Med. 2019 Oct 4;51(10):1-13. (PMID: 31586040)
Exp Ther Med. 2019 Oct;18(4):3078-3084. (PMID: 31572547)
Med Sci Monit. 2015 Oct 24;21:3222-30. (PMID: 26498375)
IUBMB Life. 2020 Mar;72(3):343-360. (PMID: 31889417)
Oncol Lett. 2020 Dec;20(6):390. (PMID: 33193850)
Nat Immunol. 2008 Apr;9(4):405-14. (PMID: 18327259)
Transl Res. 2011 Apr;157(4):253-64. (PMID: 21420036)
Dev Cell. 2013 Feb 11;24(3):283-95. (PMID: 23410941)
Int J Mol Sci. 2016 Oct 13;17(10):. (PMID: 27754357)
Med Princ Pract. 2018;27(6):501-507. (PMID: 30173215)
Scand J Immunol. 2010 Apr;71(4):227-31. (PMID: 20384865)
Lancet. 2016 Oct 22;388(10055):2023-2038. (PMID: 27156434)
Biochim Biophys Acta. 2016 Dec;1863(12):2881-2891. (PMID: 27638301)
Arthritis Res Ther. 2008;10(4):R101. (PMID: 18759964)
Cancer Gene Ther. 2016 Jul;23(7):199-205. (PMID: 27199220)
Arthritis Rheum. 2010 Jun;62(6):1576-82. (PMID: 20191579)
Cells. 2020 Apr 03;9(4):. (PMID: 32260219)
Arch Toxicol. 2016 Oct;90(10):2405-19. (PMID: 27557899)
Osteoarthritis Cartilage. 2017 Apr;25(4):521-532. (PMID: 27884646)
Prim Care. 2018 Jun;45(2):237-255. (PMID: 29759122)
Lancet. 2017 Jun 10;389(10086):2328-2337. (PMID: 28612747)
Cardiovasc Res. 2012 Mar 15;93(4):614-22. (PMID: 22135162)
Front Cell Dev Biol. 2021 Jul 14;9:625497. (PMID: 34336816)
Nature. 2004 Sep 16;431(7006):350-5. (PMID: 15372042)
J Alzheimers Dis. 2019;72(s1):S117-S130. (PMID: 31524168)
BBA Clin. 2014 Dec 09;3:79-89. (PMID: 26673737)
Br J Rheumatol. 1998 May;37(5):491-5. (PMID: 9651074)
Nat Commun. 2021 Jul 6;12(1):4148. (PMID: 34230481)
Cell. 2005 Jan 14;120(1):21-4. (PMID: 15652478)
Arthritis Res Ther. 2010;12(3):R86. (PMID: 20470394)
J Clin Transl Res. 2016 Sep 15;2(3):84-90. (PMID: 30873466)
Bone Res. 2018 Apr 27;6:15. (PMID: 29736302)
Ann Rheum Dis. 2012 Oct;71(10):1716-23. (PMID: 22562984)
J Bone Miner Res. 2013 May;28(5):1050-60. (PMID: 23225119)
Brain Res. 2010 Jun 18;1338:89-99. (PMID: 20303342)
Curr Opin Cell Biol. 2009 Jun;21(3):461-9. (PMID: 19278845)
Nat Rev Cancer. 2006 Nov;6(11):857-66. (PMID: 17060945)
J Korean Med Sci. 2015 Oct;30(10):1375-80. (PMID: 26425032)
Tumour Biol. 2016 Mar;37(3):3215-25. (PMID: 26432332)
المشرفين على المادة: 0 (MicroRNAs)
0 (Biomarkers)
0 (Mirn140 microRNA, human)
0 (MIRN455 microRNA, human)
تواريخ الأحداث: Date Created: 20240119 Date Completed: 20240122 Latest Revision: 20240122
رمز التحديث: 20240122
مُعرف محوري في PubMed: PMC10798721
DOI: 10.1097/MD.0000000000036595
PMID: 38241560
قاعدة البيانات: MEDLINE
الوصف
تدمد:1536-5964
DOI:10.1097/MD.0000000000036595